Yijieangke-B (01541.HK): The first patient of the IMC-003/IMM72 Phase I clinical trial has been successfully treated.

"Financial APP News from Straight Financial, Yimingang Technology-B (01541.HK) announced that the first patient of the IMC-003/IMM72 Phase I clinical trial has successfully received the medication, marking a major milestone in the group's IMC-003/IMM72 clinical research and laying a solid foundation for promoting subsequent clinical trials."